Literature DB >> 25453796

Synthesis and evaluation of fluoro substituted pyridinylcarboxamides and their phenylazo analogues for potential dopamine D3 receptor PET imaging.

Natascha Nebel, Simone Maschauer, Amelie L Bartuschat, Stefanie K Fehler, Harald Hübner, Peter Gmeiner, Torsten Kuwert, Markus R Heinrich, Olaf Prante, Carsten Hocke.   

Abstract

A series of fluoro substituted pyridinylcarboxamides and their phenylazo analogues with high affinity and selectivity for the dopamine D3 receptor was synthesized by the use of 6-fluoropyridine-3-carbonyl chloride (1) and fluorophenylazocarboxylic ester (2). Several of these compounds (9a-e and 10a-h) have been evaluated in vitro, among which 9b, 10a, 10c and 10d proved to have at least single-digit nanomolar affinity for D3. They also exhibit considerable selectivity over the other dopamine receptor subtypes and noteworthy selectivity over the structurally related serotonin receptor subtypes 5-HT(1A) and 5-HT₂, offering potential radiotracers for positron emission tomography.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25453796     DOI: 10.1016/j.bmcl.2014.10.043

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Synthesis and pre-clinical evaluation of a potential radiotracer for PET imaging of the dopamine D3 receptor.

Authors:  Megan N Stewart; Xia Shao; Timothy J Desmond; Taylor J Forrest; Janna Arteaga; Jenelle Stauff; Peter J H Scott
Journal:  Medchemcomm       Date:  2018-06-29       Impact factor: 3.597

2.  [18F]Fluorophenylazocarboxylates: Design and Synthesis of Potential Radioligands for Dopamine D3 and μ-Opioid Receptor.

Authors:  Natascha Nebel; Brigitte Strauch; Simone Maschauer; Roman Lasch; Hannelore Rampp; Stefanie K Fehler; Leonard R Bock; Harald Hübner; Peter Gmeiner; Markus R Heinrich; Olaf Prante
Journal:  ACS Omega       Date:  2017-12-06

3.  Synthesis, Radiosynthesis and Biological Evaluation of Buprenorphine-Derived Phenylazocarboxamides as Novel μ-Opioid Receptor Ligands.

Authors:  Jasmin Krüll; Stefanie K Fehler; Laura Hofmann; Natascha Nebel; Simone Maschauer; Olaf Prante; Peter Gmeiner; Harald Lanig; Harald Hübner; Markus R Heinrich
Journal:  ChemMedChem       Date:  2020-06-02       Impact factor: 3.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.